Page last updated: 2024-08-22

angiotensin ii and Infections, Pseudomonas

angiotensin ii has been researched along with Infections, Pseudomonas in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Evans, H; Ho, VP; Kaafarani, H; Namias, N; Rattan, R; Zakrison, TL	1
Alvarez, C; Castello, L; Geffner, J; Giordano, M; Nahmod, V; Pereyra, Y; Raiden, S	1

Reviews

1 review(s) available for angiotensin ii and Infections, Pseudomonas

Article	Year
Sepsis 2019: What Surgeons Need to Know. Surgical infections, 2020, Volume: 21, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex	2020

Article

Year

Sepsis 2019: What Surgeons Need to Know.

Surgical infections, 2020, Volume: 21, Issue:3

Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex

2020

Other Studies

1 other study(ies) available for angiotensin ii and Infections, Pseudomonas

Article	Year
Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP. Journal of leukocyte biology, 2000, Volume: 68, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Movement; Chemotaxis, Leukocyte; Hemorrhage; Losartan; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2000

Article

Year

Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP.

Journal of leukocyte biology, 2000, Volume: 68, Issue:5

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Movement; Chemotaxis, Leukocyte; Hemorrhage; Losartan; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2000